lanthanum has been researched along with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, W; Elbling, L; Heffeter, P; Jakupec, MA; Keppler, BK; Knasmüller, S; Körner, W; Korynevska, A; Micksche, M; Sutterlüty, H; von Keyserlingk, NG; Wild, S; Zorbas, H | 1 |
1 other study(ies) available for lanthanum and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine
| Article | Year |
|---|---|
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Bleomycin; Carbocyanines; Caspases; Cell Death; Cell Line, Tumor; Cell Proliferation; Comet Assay; Cytoskeleton; DNA Damage; Dose-Response Relationship, Drug; Fluorescent Dyes; G1 Phase; HL-60 Cells; Humans; Injections, Intravenous; Intercalating Agents; Lanthanum; Mice; Mice, Nude; Molecular Structure; Nucleic Acid Synthesis Inhibitors; Organometallic Compounds; Phenanthrolines; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Resting Phase, Cell Cycle; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2006 |